Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q57312402)
Watch
English
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
article
In more languages
edit
Statements
instance of
scholarly article
0 references
title
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
(English)
0 references
main subject
patient
0 references
glucose
0 references
type 2 diabetes
1 reference
based on heuristic
inferred from title
author
Vlado Perkovic
object named as
Vlado Perkovic
series ordinal
1
0 references
Sophia Zoungas
object named as
Sophia Zoungas
series ordinal
16
0 references
Michel Marre
object named as
Michel Marre
series ordinal
10
0 references
John Chalmers
object named as
John Chalmers
series ordinal
3
0 references
Pavel Hamet
series ordinal
9
object named as
Pavel Hamet
0 references
Alan Cass
object named as
Alan Cass
series ordinal
14
0 references
Min Jun
object named as
Min Jun
series ordinal
5
0 references
Giuseppe Mancia
series ordinal
13
object named as
Giuseppe Mancia
0 references
Neil R Poulter
series ordinal
12
object named as
Neil Poulter
0 references
Anushka Patel
series ordinal
15
object named as
Anushka Patel
0 references
Stephen MacMahon
series ordinal
7
object named as
Stephen MacMahon
0 references
Carl Erik Mogensen
series ordinal
11
object named as
Carl Erik Mogensen
0 references
Hiddo J L Heerspink
series ordinal
2
object named as
Hiddo Lambers Heerspink
0 references
author name string
Mark Woodward
series ordinal
4
0 references
Qiang Li
series ordinal
6
0 references
Mark E. Cooper
series ordinal
8
0 references
language of work or name
English
0 references
publication date
March 2013
0 references
published in
Kidney International
0 references
volume
83
0 references
issue
3
0 references
page(s)
517-523
0 references
exact match
https://scigraph.springernature.com/pub.10.1038/ki.2012.401
0 references
cites work
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preventing microalbuminuria in type 2 diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of intensive glucose lowering in type 2 diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glucose control and vascular complications in veterans with type 2 diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Albuminuria as a surrogate marker for drug development: a European Regulatory perspective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Of fads, fashion, surrogate endpoints and dual RAS blockade
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diabetic kidney disease with and without albuminuria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Standards of medical care in diabetes--2011.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
10-year follow-up of intensive glucose control in type 2 diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reversal of lesions of diabetic nephropathy after pancreas transplantation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Telmisartan, ramipril, or both in patients at high risk for vascular events
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is Doubling of Serum Creatinine a Valid Clinical ‘Hard’ Endpoint in Clinical Nephrology Trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sitagliptin reduces albuminuria in patients with type 2 diabetes.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FKI.2012.401
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/KI.2012.401
0 references
PubMed ID
23302714
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit